Adverse events occurred in @ ( @ % ) of @ patients in the rosuvastatin @ mg group versus @ ( @ % ) of @ patients in the rosuvastatin @ mg group versus @ ( @ % ) of @ patients in the atorvastatin @ mg group ; renal events occurred in nine ( @ % ) versus @ ( @ % ) versus five ( @ % ) .